Abstract
An ethical dilemma of a patient with severe alopecia areata insisting on treatment with a novel oral Janus kinase inhibitor, despite the dermatologist expressing reservations about the patient’s cardiovascular risk factors.

This publication has 3 references indexed in Scilit: